CLINICAL_TRIALS
trial_result
· 2024-07-16
Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Obesity Disease [Phase 3]
Summary
A Phase 3 clinical trial update for tirzepatide (LY3298176) in obesity shows the study has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Obesity | Phase 3 | Status: COMPLETED | Results posted: 2024-07-16